Related Experiment Videos
Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.
Q Zhou1, M T Nakada, P C Brooks
1Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, 90033, USA.
Biochemical and Biophysical Research Communications
|January 7, 2000
Summary
Contortrostatin, a snake venom disintegrin, binds to integrin alphavbeta5. This interaction inhibits alphavbeta5-mediated cell adhesion and invasion, revealing a new therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Contortrostatin is a homodimeric disintegrin found in snake venom.
- Previous studies indicated contortrostatin binds to integrins alphaIIbbeta3, alpha5beta1, and alphavbeta3.
Purpose of the Study:
- To investigate and confirm the binding of contortrostatin to the integrin alphavbeta5.
- To elucidate the functional consequences of contortrostatin binding to alphavbeta5.
Main Methods:
- Cell adhesion assays using T24 cells and a T24 subline with vitronectin.
- Invasion assays with OVCAR-5 cells.
- Saturation binding assays with purified alphavbeta5.
- Radioligand binding assays to determine the dissociation constant (Kd).
Main Results:
- Contortrostatin, alone or with specific antibodies, blocked T24 cell adhesion to vitronectin, indicating interaction with alphavbeta5.
- Contortrostatin inhibited invasion of OVCAR-5 cells, which express alphavbeta5.
- Binding of contortrostatin to purified alphavbeta5 was saturable.
- Radioligand assays determined a Kd of 24 nM for [(125)I]contortrostatin binding to alphavbeta5.
Conclusions:
- This study identifies alphavbeta5 as a direct binding site for contortrostatin.
- Contortrostatin effectively inhibits alphavbeta5-mediated cell adhesion and invasion.
- Alphavbeta5 represents a potential therapeutic target for contortrostatin-based interventions.